You just read:

Scintilla Pharmaceuticals, Inc., a Subsidiary of Sorrento Therapeutics, Inc., to Acquire Semnur Pharmaceuticals, Inc. to Further Deepen its Pain Management Pipeline

News provided by

Sorrento Therapeutics, Inc.

Aug 15, 2016, 18:34 ET